SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,800.00    105.00 (1.57%)
Bid:
6,795.00
Ask:
6,800.00
Spread: 5.00 (0.074%)
Market Cap: £5.02b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 Nov 2009 07:00

RNS Number : 1535C
Spirax-Sarco Engineering PLC
09 November 2009
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Monday 9th November 2009

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the period since 1st July 2009.

Trading

Since the half year, the pace of decline in our sales has stabilised. Sales for the year to date through October were down 9% in constant currency against strong results last year. Exchange rates have continued to be favourable and have added 10% to Group revenues in 2009 compared with average exchange rates in calendar year 2008.

Trading margin this year has benefited from exchange rates and, since the end of the half year, has benefited from lower materials costs and reduced operating costs. We have completed the announced headcount reductions which, together with further attrition, means our headcount is now 7% lower than the start of the year. The reductions are largely in manufacturing and administrative support, with cost benefits in the second half year and continuing to be delivered in 2010.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 31st October 2009 of £1m despite funding the acquisition of MasoSine in August for £22m and Intervalf in October for £3m. There has been no material change in the financial position of the Group during the period. Capital investment is well above the level in recent years as we continue to invest in projects with good returns to deliver more efficient manufacturing processes and capacity expansion, particularly in developing markets.

Outlook

Our strong cash position has enabled us to continue to make investments in developing new products, expanding our market penetration and improving operating efficiency, even through this difficult period. The Group's strong customer value proposition and diversity of end user markets, customers, products and geographic spread, give us confidence in our future prospects.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBXUGGGCL
Date   Source Headline
8th Jun 20104:13 pmRNSDirector/PDMR Shareholding
4th Jun 20102:17 pmRNSHolding(s) in Company
1st Jun 20101:34 pmRNSTotal Voting Rights
28th May 20103:20 pmRNSDirector/PDMR Shareholding
25th May 20101:30 pmRNSAcquisition
21st May 20104:56 pmRNSDirector/PDMR Shareholding
14th May 20104:01 pmRNSDirector/PDMR Shareholding
14th May 201011:06 amRNSAGM Statement
11th May 20105:16 pmRNSDirector/PDMR Shareholding
11th May 20105:13 pmRNSAGM Statement
11th May 20101:00 pmRNSInterim Management Statement
4th May 201011:29 amRNSTotal Voting Rights
14th Apr 20104:04 pmRNSHolding(s) in Company
1st Apr 20109:13 amRNSTotal Voting Rights
29th Mar 20104:20 pmRNSDirector/PDMR Shareholding
29th Mar 20104:17 pmRNSHolding(s) in Company
25th Mar 201011:40 amRNSAnnual Financial Report
10th Mar 20104:21 pmRNSDirector/PDMR Shareholding
9th Mar 20105:16 pmRNSDirector/PDMR Shareholding
8th Mar 20106:15 pmRNSDirector/PDMR Shareholding
5th Mar 20104:18 pmRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNS2009 Preliminary Results
1st Mar 20106:07 pmRNSTotal Voting Rights
1st Feb 201011:13 amRNSTotal Voting Rights
1st Feb 201011:10 amRNSTotal Voting Rights - Replacement
18th Jan 20109:17 amRNSNotice of Results
8th Jan 20107:00 amRNSTrading Update
4th Jan 201010:36 amRNSTotal Voting Rights
4th Dec 20092:35 pmRNSHolding(s) in Company
1st Dec 20094:41 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20093:58 pmRNSTotal Voting Rights
1st Dec 20093:56 pmRNSDirector/PDMR Shareholding
26th Nov 20091:49 pmRNSDirector Declaration
9th Nov 20093:42 pmRNSDirector/PDMR Shareholding
9th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 20098:37 amRNSTotal Voting Rights
9th Oct 20093:21 pmRNSDirector/PDMR Shareholding
6th Oct 200912:34 pmRNSHolding(s) in Company
2nd Oct 20092:08 pmRNSHolding(s) in Company
2nd Oct 20098:30 amRNSAcquisition
1st Oct 200911:56 amRNSTotal Voting Rights
29th Sep 20094:29 pmRNSDirector/PDMR Shareholding
24th Sep 20091:49 pmRNSDirector/PDMR Shareholding
4th Sep 20092:24 pmRNSTotal Voting Rights
27th Aug 20093:32 pmRNSAcquisition
20th Aug 20097:00 amRNS2009 Half Year Results
5th Aug 20092:07 pmRNSNotice of Results
3rd Aug 20092:56 pmRNSTotal Voting Rights
16th Jul 20094:30 pmRNSDirectorate Change
2nd Jul 20093:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.